Zymergen Inc
ZY
Get informed when a big investor buys or sells
+ FollowMarket Cap$0
Close$
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $-23,067,000.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.87 |
| Beta | 0 |
| Outstanding Shares | 103,482,907 |
Return
| Return on Equity | -154.23% |
|---|---|
| Return on Assets | -77.49% |
| Return on Invested Capital | -80.78% |
Valuation & Multiples
| P/E Ratio | -0.5 |
|---|---|
| PEG | -3.22 |
| Price to Sales | - |
| Price to Book Ratio | 1.22 |
| Enterprise Value to Revenue | -1.64 |
| Enterprise Value to EBIT | 0.07 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -8.26 |
| Debt to Equity | 0.81 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Zymergen Inc
758 employees
CEO: Joshua Hoffman Zymergen is a biofacturing company using biology to reimagine the world. Zymergen partners with nature to create, develop and manufacture breakthrough products and materials across a broad range of industries.